Oral tolerance induction in humans

Experimental and Molecular Pathology

Volumn 93, Issue 3, 2012, Pages 449-454

  Meyer, Tim ^a   Ullrich, Reiner ^a   Zeitz, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokine; Keyhole limpet hemocyanin; Oral tolerance; T cell proliferation

Indexed keywords

ANTIGEN; AUTOANTIGEN; CD40 ANTIGEN; CD40 LIGAND; COLLAGEN TYPE 1; GAMMA INTERFERON; HLA B27 ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; KEYHOLE LIMPET HEMOCYANIN; MYELIN; PROTEIN DNAJ; THYROTROPIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CELL COMMUNICATION; CELL INTERACTION; CYTOKINE PRODUCTION; DISEASE COURSE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; EXPERIMENTAL MODEL; GASTROINTESTINAL MUCOSA; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NONHUMAN; ORAL TOLERANCE; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; THYROID DISEASE; TREATMENT OUTCOME; UVEITIS;

ANIMALS; ANTIBODY FORMATION; AUTOIMMUNE DISEASES; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HEMOCYANIN; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; MOUTH MUCOSA;

ANIMALIA; RODENTIA;

EID: 84870713655     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.10.002     Document Type: Review

References (36)

1. Benson J.M., Whitacre C.C. The role of clonal deletion and anergy in oral tolerance. Research in Immunology 1997, 148:533-541.
2. Chase M.W. Inhibition of experimental drug allergy by prior feeding of the sensitizing agent. Proceedings of the Society for Experimental Biology and Medicine 1946, 61:257-259.
3. Chen Y., Inobe J., Marks R., Gonnella P., Kuchroo V.K., Weiner H.L. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995, 376:177-180.
4. da Silva A.C., de Souza K.W., Machado R.C., da Silva M.F., Sant'Anna O.A. Genetics of immunological tolerance: I Bidirectional selective breeding of mice for oral tolerance. Research in Immunology 1998, 149:151-161.
5. da Silva M.F., da Costa S.C., Ribeiro R.C., Sant'Anna O.A., da Silva A.C. Independent genetic control of B- and T-cell tolerance in strains of mouse selected for extreme phenotypes of oral tolerance. Scandinavian Journal of Immunology 2001, 53:148-154.
6. Duchmann R., Neurath M.F., Meyer zum Buschenfelde K.H. Responses to self and non-self intestinal microflora in health and inflammatory bowel disease. Research in Immunology 1997, 148:589-594.
7. Faria A.M., Maron R., Ficker S.M., Slavin A.J., Spahn T., Weiner H.L. Oral tolerance induced by continuous feeding: enhanced up-regulation of transforming growth factor-beta/interleukin-10 and suppression of experimental autoimmune encephalomyelitis. Journal of Autoimmunity 2003, 20:135-145.
8. Frentsch M., Arbach O., Kirchhoff D., Moewes B., Worm M., Rothe M., Scheffold A., Thiel A. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nature Medicine 2005, 11:1118-1124.
9. Fukaura H., Kent S.C., Pietrusewicz M.J., Khoury S.J., Weiner H.L., Hafler D.A. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. The Journal of Clinical Investigation 1996, 98:70-77.
10. Hanninen A., Harrison L.C. Mucosal tolerance to prevent type 1 diabetes: can the outcome be improved in humans?. The Review of Diabetic Studies 2004, 1:113-121.
11. Higgins P.J., Weiner H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. Journal of Immunology 1988, 140:440-445.
12. Husby S., Mestecky J., Moldoveanu Z., Holland S., Elson C.O. Oral tolerance in humans T cell but not B cell tolerance after antigen feeding. Journal of Immunology 1994, 152:4663-4670.
13. Kantele A., Hakkinen M.P., Zivny J., Elson C.O., Mestecky J., Kantele J.M. Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines. Clinical and Developmental Immunology 2011, 2011:614383.
14. Kapp K., Maul J., Hostmann A., Mundt P., Preiss J.C., Wenzel A., Thiel A., Zeitz M., Ullrich R., Duchmann R. Modulation of systemic antigen-specific immune responses by oral antigen in humans. European Journal of Immunology 2010, 40:3128-3137.
15. Kelsall B.L., Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunology Reviews 2005, 206:132-148.
16. Koffeman E.C., Genovese M., Amox D., Keogh E., Santana E., Matteson E.L., Kavanaugh A., Molitor J.A., Schiff M.H., Posever J.O., Bathon J.M., Kivitz A.J., Samodal R., Belardi F., Dennehey C., van den Broek T., van Wijk F., Zhang X., Zieseniss P., Le T., Prakken B.A., Cutter G.C., Albani S. Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial. Arthritis and Rheumatism 2009, 60:3207-3216.
17. Kraus T.A., Toy L., Chan L., Childs J., Cheifetz A., Mayer L. Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk. Annals of the New York Academy of Sciences 2004, 1029:225-238.
18. Kraus T.A., Cheifetz A., Toy L., Meddings J.B., Mayer L. Evidence for a genetic defect in oral tolerance induction in inflammatory bowel disease. Inflammatory Bowel Diseases 2006, 12:82-88.
19. Kumanogoh A., Wang X., Lee I., Watanabe C., Kamanaka M., Shi W., Yoshida K., Sato T., Habu S., Itoh M., Sakaguchi N., Sakaguchi S., Kikutani H. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development. Journal of Immunology 2001, 166:353-360.
20. Kushwah R., Hu J. Dendritic cell apoptosis: regulation of tolerance versus immunity. Journal of Immunology 2010, 185:795-802.
21. Lee S., Scherberg N., DeGroot L.J. Induction of oral tolerance in human autoimmune thyroid disease. Thyroid 1998, 8:229-234.
22. Lievens D., Eijgelaar W.J., Biessen E.A., Daemen M.J., Lutgens E. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thrombosis and Haemostasis 2009, 102:206-214.
23. Mayer L., Shao L. Therapeutic potential of oral tolerance. Nature Reviews Immunology 2004, 4:407-419.
24. McKown K.M., Carbone L.D., Bustillo J., Seyer J.M., Kang A.H., Postlethwaite A.E. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthritis and Rheumatism 2000, 43:1054-1061.
25. Moldoveanu Z., Oliver F., Mestecky J., Elson C.O. Oral tolerance in humans: failure to suppress an existing immune response by oral antigen administration. Annals of the New York Academy of Sciences 2004, 1029:299-309.
26. Monetini L., Cavallo M.G., Sarugeri E., Sentinelli F., Stefanini L., Bosi E., Thorpe R., Pozzilli P. Cytokine profile and insulin antibody IgG subclasses in patients with recent onset type 1 diabetes treated with oral insulin. Diabetologia 2004, 47:1795-1802.
27. Mowat A.M., Steel M., Leishman A.J., Garside P. Normal induction of oral tolerance in the absence of a functional IL-12-dependent IFN-gamma signaling pathway. Journal of Immunology 1999, 163:4728-4736.
28. Myers L.K., Higgins G.C., Finkel T.H., Reed A.M., Thompson J.W., Walton R.C., Hendrickson J., Kerr N.C., Pandya-Lipman R.K., Shlopov B.V., Stastny P., Postlethwaite A.E., Kang A.H. Juvenile arthritis and autoimmunity to type II collagen. Arthritis and Rheumatism 2001, 44:1775-1781.
29. Nagler-Anderson C., Bober L.A., Robinson M.E., Siskind G.W., Thorbecke G.J. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proceedings of the National Academy of Sciences of the United States of America 1986, 83:7443-7446.
30. Pabst O., Mowat A.M. Oral tolerance to food protein. Mucosal Immunology 2012, 5:232-239.
31. Pozzilli P., Pitocco D., Visalli N., Cavallo M.G., Buzzetti R., Crino A., Spera S., Suraci C., Multari G., Cervoni M., Manca Bitti M.L., Matteoli M.C., Marietti G., Ferrazzoli F., Cassone Faldetta M.R., Giordano C., Sbriglia M., Sarugeri E., Ghirlanda G. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 2000, 43:1000-1004.
32. Rizzo L.V., Morawetz R.A., Miller-Rivero N.E., Choi R., Wiggert B., Chan C.C., Morse H.C., Nussenblatt R.B., Caspi R.R. IL-4 and IL-10 are both required for the induction of oral tolerance. Journal of Immunology 1999, 162:2613-2622.
33. Sun J.B., Czerkinsky C., Holmgren J. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scandinavian Journal of Immunology 2010, 71:1-11.
34. Thurau S.R., Diedrichs-Mohring M., Fricke H., Burchardi C., Wildner G. Oral tolerance with an HLA-peptide mimicking retinal autoantigen as a treatment of autoimmune uveitis. Immunology Letters 1999, 68:205-212.
35. Weiner H.L., da Cunha A.P., Quintana F., Wu H. Oral tolerance. Immunology Reviews 2011, 241:241-259.
36. Zhang Z.J., Davidson L., Eisenbarth G., Weiner H.L. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:10252-10256.